Literature DB >> 6339500

On the fidelity of DNA replication. Mechanisms of misincorporation by intercalating agents.

C W Shearman, M M Forgette, L A Loeb.   

Abstract

Two distinct mechanisms of action for intercalating agents have been delineated: one leading to the production of frameshift misincorporations and the other leading to the production of single-base substitutions. Addition misincorporations are competitive with respect to DNA template (a measure of classical intercalation) but are not competitive with respect to deoxynucleotide substrates. Single-base substitutions are not competitive with template, polymerase, or deoxynucleotide as tested individually, but are proportional to the absolute drug concentration, indicating a ternary complex involving intercalator, polymerase, and template. Increased frequencies of single-base substitutions have not been considered as a general property of intercalators. Using a mutant phi X174 DNA, we demonstrate that intercalators also induce single-base substitutions with natural DNA templates. Reversion of am3 phi X174 DNA occurs only by single-base substitutions at position 587; this is increased 8-fold when the DNA is copied in vitro in the presence of intercalators.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339500

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  An in vitro assay for frameshift mutations: hotspots for deletions of 1 bp by Klenow-fragment polymerase share a consensus DNA sequence.

Authors:  J G de Boer; L S Ripley
Journal:  Genetics       Date:  1988-02       Impact factor: 4.562

2.  Human base excision repair creates a bias toward -1 frameshift mutations.

Authors:  Derek M Lyons; Patrick J O'Brien
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

Review 3.  Sequence specificities in the interactions of chemicals and radiations with DNA.

Authors:  R J Wilkins
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.